All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...

Research shows semaglutide, for diabetes and weight loss, may slightly increase vision risk, linked to a rare condition causing sudden, irreversible vision loss from optic nerve damage.

Many Americans are taking GLP1 medications, which include weight loss and diabetes medications Ozempic and Wegovy.

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Two years on from The Royal Gazette’s first report on a new wave of diabetes drugs with broader health benefits, the island’s ...

Popular medications for obesity and diabetes have been linked to an increased risk of hair loss, particularly for women. Researchers and doctors weigh in.

Those who experience hair loss while taking semaglutide drugs should consult with a dermatologist ... “This is a relatively new adverse event, and not much is known about it,” he said.

Results from the rather large, international trial were published in the New England Journal ... group (no medication) and a drug group to see if those taking oral semaglutide were more or less ...

A Howard County man is suing Novo Nordisk, alleging Ozempic caused him to go blind after using the drug to treat diabetes. He seeks damages in court.

Share on Pinterest The FDA’s new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Images Provided by ...